Roger I. Gale serves as Executive at CALYPTE BIOMEDICAL CORP, where they oversee executive responsibilities. Since joining the company, Roger I. Gale has executed 5 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Apr 1, 2008 involved receiving (via award) 323,669 shares valued at $25.9K.
Roger I. Gale currently holds 12,072,275 shares of CALYPTE BIOMEDICAL CORP (HIV), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Roger I. Gale has been a net neutral trader of HIV stock. They have purchased $0 and sold $0 worth of shares.
Roger I. Gale's most recent insider trade was on Apr 1, 2008, when they sold 323,669 shares at $0.08 per share.
Get notified when new Form 4 filings are submitted
| $0.05 |
| Discretionary |
| Jan 19, 2007 | CBMC.OB | $0 | Award | 2,000,000 | $N/A | Discretionary |
| Feb 8, 2006 | HIV | $0 | Award | 311,736 | $N/A | Discretionary |
| Jan 4, 2006 | HIV | $0 | Award | 1,000,000 | $N/A | Discretionary |